30 August 2022>: Articles
Thrombotic Thrombocytopenic Purpura Triggered by Acute Myeloid Leukemia: A Case Report
Rare coexistence of disease or pathology
Ijele Adimora E* , Cristhiam M. Rojas Hernandez EDOI: 10.12659/AJCR.935911
Am J Case Rep 2022; 23:e935911
Table 1. Summary of laboratory markers throughout the hospital course.
Laboratory markers | On admission | At decompensation (8/16) | One day after PLEX (8/19) | Fifteen days after PLEX (9/18) |
---|---|---|---|---|
Hemoglobin (g/dL) | 7.9 | 8.6 | 8.8 | 8.5 |
Platelet count (K/µL) | 30×10 | 14×10 | 42×10 | 42×10 |
Haptoglobin (mg/dL) | – | 314 | 118 | – |
ADAMTS13 (%) | – | 10 | – | 51 |
Creatinine (mg/dL) | 1.49 | 5.4 | 1.1 | 1.09 |
LDH (U/L) | 1035 | 868 | 499 | 476 |
INR | 1.33 | 1.60 | 1.80 | 1.45 |
Ind bilirubin (mg/dL) | 0.5 | 0.5 | 0.8 | 2.5 |
Dash indicate no data at time of measurement. PLEX – plasma exchange therapy; INR – international normalized ratio; LDH – lactate dehydrogenase. |